nicehed...@yahoo.com

Fact #1 since Sept. 3, 2008 SIGA has secured $79,618,000 in funding
for development of it's drug pipeline.

*BREAKDOWN*

$20,000,000 Sept 18

$3,655,000 Sept 15

$963,000 Sept. 12

$55,000,000 Sept. 3

Fact #2 on Sept 2 SIGA's share price closed at $3.77 The above funding
news is not priced in at all, YET! The value of such funding is
delayed in terms of stock price only because the large players gather
as many shares cheap as can be shaken from weak hands. The step of
gathering shares is near completion. Will you risk missing the large
run when at this price it's well bellow value?

Fact #3 BARDA & National Institute of Allergy & Infectious Diseases
(NIAID) will for emergency stockpiling of ST-246 contract for
$300,000,000 - $500,000,000. Contracts this size have moved other like
stocks well over $22 a share, in fact the $79,618,000 should have run
SIGA to the $10 area.

Fact#4 The true value of a companies stock will always be valued in,
just not as soon as the smaller players want it because they always
want immediate results & that is just not the nature of the game. This
is a controlled game & big money controls!

Fact #5 The rise will happen before the end of October on a likely
Emergency contract for stockpile.

Not even listed is the fact SIGA is a potential buyout target. SIGA
Tech. is now testing a commercial anti-viral pipleline & when that
news leaks it will be a real gold rush. You must understand why SIGA
sits on that news (It's related to buyout patrons). It's all good load
while this is under $5, in fact this is cheap all under $6 due to
recent news.